I’m not sure what to make of this announcement. We’re in the business of developing MDMA like compounds for therapeutic use, yet we’ve just gone and bought some from a supplier and it seems like we’re going to move into more of an enabler type role than as a supplier ourselves.
Its a little confusing and I guess the concern is with what about all the companies research and development? Does the rescheduling mean “MDMA LIKE” research is not necessary now as actual MDMA is now going to be available?
Please note I sold last week on the hype, until the pathway became clearer for commercial opportunities. It’s exciting but I’m not sure where we fit into this market right now.
- Forums
- ASX - By Stock
- Ann: Emyria secures clinical-grade MDMA supply for Aust patients
I’m not sure what to make of this announcement. We’re in the...
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.81M |
Open | High | Low | Value | Volume |
4.7¢ | 4.8¢ | 4.6¢ | $8.939K | 194.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2755 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 39796 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2755 | 0.046 |
7 | 512222 | 0.045 |
1 | 150000 | 0.043 |
2 | 95820 | 0.042 |
1 | 50000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 39796 | 1 |
0.050 | 280869 | 4 |
0.055 | 8341 | 1 |
0.058 | 13333 | 1 |
0.059 | 110000 | 1 |
Last trade - 15.55pm 20/06/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online